NEW YORK and ORMAND BEACH, Fla. – October 18, 2022 – Ew Healthcare Partners, a prominent name in healthcare investment, has announced the strategic acquisition of Germfree Laboratories, Inc., a leading U.S. manufacturer specializing in advanced cleanroom and biocontainment solutions. This acquisition marks a significant expansion for EW Healthcare Partners into the critical infrastructure sector supporting biopharmaceutical manufacturing and research.
Germfree Laboratories, established in 1962, has built a strong reputation for providing turnkey, mobile, and modular cleanrooms, along with essential equipment and services for controlled environments. The company’s solutions are vital for industries requiring stringent contamination control, particularly within healthcare and life sciences. With a substantial footprint of over 200 facilities across six continents and a dedicated workforce of nearly 200 employees at its Florida-based manufacturing plant, Germfree has demonstrated consistent growth and global reach. Their 173,000 ft² (16,000 m²) environmentally controlled facility underscores their commitment to quality and scale in production.
Evis Hursever, Managing Director at EW Healthcare Partners, highlighted the increasing demand for Germfree’s specialized offerings. “The biopharmaceutical industry is experiencing a surge in demand for mobile and modular cleanrooms. This is driven by the rapid evolution of new technologies, capacity pressures, and the need for adaptable, fast-delivery solutions,” Hursever stated. “Germfree is uniquely positioned to address this critical need by providing cutting-edge cleanroom solutions designed for specialized and flexible cGMP-compliant manufacturing spaces. EW Healthcare Partners is excited to collaborate with Kevin Kyle and the Germfree team to accelerate their growth, particularly within the rapidly expanding Advanced Therapy Medicinal Products (ATMP) sector.”
Kevin Kyle, CEO of Germfree, also expressed enthusiasm about the partnership. “Joining forces with EW Healthcare Partners positions Germfree to significantly scale our manufacturing capabilities and address the biomanufacturing capacity gap within the biopharmaceutical industry,” Kyle commented. “EW Healthcare Partners is the ideal partner to support Germfree’s growth trajectory. Our shared commitment to driving innovation in healthcare and biopharma, combined with their dedication to our long-term success, creates a powerful strategic alignment. Furthermore, EW’s deep expertise in advanced therapeutics and their extensive global network will provide invaluable synergy as we expand our solutions to meet the growing demands in areas like cell and gene therapy.”
For EW Healthcare Partners, this acquisition strategically enhances their portfolio by incorporating a key player in biomanufacturing infrastructure. Germfree’s expertise in mobile and modular cleanrooms is particularly relevant in today’s dynamic healthcare landscape, where flexibility and speed are paramount.
The financial details of the transaction were not disclosed. EW Healthcare Partners received legal counsel from Kirkland & Ellis, with A&M acting as financial due diligence and tax advisor, and BCG providing commercial due diligence advisory services. Germfree Laboratories was advised by Jefferies LLC as exclusive financial advisor and Holland & Knight LLP for legal counsel.
About EW Healthcare Partners
With a substantial capital base exceeding $4 billion since its inception, EW Healthcare Partners stands as a leading and long-established private healthcare investment firm. The firm focuses on growth equity investments in rapidly expanding commercial-stage healthcare companies across pharmaceuticals, medical devices, diagnostics, and technology-enabled services within the United States and Europe. Since its founding in 1985, EW Healthcare Partners has remained steadfast in its commitment to the healthcare sector, investing in over 150 companies across diverse sectors, stages, and geographies. Their experienced team comprises over 20 senior investment professionals operating from offices in New York, London, and Houston. For more information, please visit: https://www.ewhealthcare.com/
About Germfree Laboratories, Inc.
Germfree Laboratories has been a pioneer in creating critical environments for life science innovation and global health advancement for six decades. The company specializes in the design and manufacture of mobile and modular cleanrooms and high-containment laboratories, complemented by a comprehensive range of biosafety and aseptic processing equipment. Germfree’s bioGO® cleanroom solutions offer adaptable and scalable infrastructure for biopharmaceutical and advanced therapy manufacturing. With over 200 facility installations spanning 32 countries, Germfree is a global leader dedicated to empowering clients in developing life-saving treatments and preventing future pandemics. Germfree’s operations are based in Ormond Beach, Florida, housing leading-edge engineering, technology, and a team of skilled builders and subject-matter experts. Further details can be found at: https://www.germfree.com/
Contact Information:
Taylor Miller
[email protected]
(386) 265 – 4300
Anne DeMaret
[email protected]
(281) 528 – 1956
This announcement was distributed via Newswire.com, a press release distribution service.
